QT
PCRX icon

Quantamental Technologies’s Pacira BioSciences PCRX Stock Holding History

Quantamental Technologies’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,588
Closed -$276K – 229
2020
Q3 		$276K Buy
+4,588
New +$267K 0.2% 171
2020
Q1 		– Sell
-5,448
Closed -$247K – 324
2019
Q4 		$247K Buy
+5,448
New +$231K 0.13% 308
2019
Q3 		– Sell
-7,049
Closed -$307K – 1747
2019
Q2 		$307K Buy
7,049
+2,804
+66% +$119K 0.11% 294
2019
Q1 		$162K Buy
+4,245
New +$166K 0.07% 444

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Quantamental Technologies's PCRX Position: Q4 2020 in Review

Quantamental Technologies sold out of Pacira BioSciences (PCRX) in Q4 2020, closing a stake of 4,588 shares — an estimated $276K sold.

Quantamental Technologies first reported a position in PCRX in Q1 2019 and held it in 4 quarters. The position peaked at $307K in Q2 2019. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2020.

  • Quantamental Technologies reported no remaining Pacira BioSciences position as of Q4 2020 after selling out during the quarter.
  • Quantamental Technologies sold 4,588 Pacira BioSciences shares in Q4 2020, an estimated $276K.
  • Quantamental Technologies first reported a position in Pacira BioSciences in Q1 2019 and held it in 4 quarters.
  • Quantamental Technologies's Pacira BioSciences position peaked at $307K in Q2 2019.
  • 260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2020.

Based on Quantamental Technologies's 13F filing for Q4 2020, filed 16 Feb 2021.